nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Erythema multiforme—Dactinomycin—skin cancer	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Sinusitis—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Dyspepsia—Imiquimod—skin cancer	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Pneumonia—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Cefpodoxime—Decreased appetite—Imiquimod—skin cancer	0.00162	0.00162	CcSEcCtD
Cefpodoxime—Hypersensitivity—Vemurafenib—skin cancer	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Imiquimod—skin cancer	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Fatigue—Imiquimod—skin cancer	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Pain—Imiquimod—skin cancer	0.00159	0.00159	CcSEcCtD
Cefpodoxime—Renal impairment—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Cefpodoxime—Dermatitis bullous—Docetaxel—skin cancer	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Haemoglobin—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Stomatitis—Fluorouracil—skin cancer	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Haemorrhage—Temozolomide—skin cancer	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Asthenia—Vemurafenib—skin cancer	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Hallucination—Temozolomide—skin cancer	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Chills—Dactinomycin—skin cancer	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Oedema peripheral—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Pruritus—Vemurafenib—skin cancer	0.00154	0.00154	CcSEcCtD
Cefpodoxime—Alopecia—Dactinomycin—skin cancer	0.00153	0.00153	CcSEcCtD
Cefpodoxime—Feeling abnormal—Imiquimod—skin cancer	0.00153	0.00153	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Imiquimod—skin cancer	0.00152	0.00152	CcSEcCtD
Cefpodoxime—Epistaxis—Fluorouracil—skin cancer	0.00152	0.00152	CcSEcCtD
Cefpodoxime—Hyponatraemia—Docetaxel—skin cancer	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Sinusitis—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Agranulocytosis—Fluorouracil—skin cancer	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Bleomycin—skin cancer	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Anaemia—Bleomycin—skin cancer	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Diarrhoea—Vemurafenib—skin cancer	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Migraine—Docetaxel—skin cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Erythema multiforme—Temozolomide—skin cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Urticaria—Imiquimod—skin cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Abdominal pain—Imiquimod—skin cancer	0.00147	0.00147	CcSEcCtD
Cefpodoxime—Body temperature increased—Imiquimod—skin cancer	0.00147	0.00147	CcSEcCtD
Cefpodoxime—Tinnitus—Temozolomide—skin cancer	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Malaise—Bleomycin—skin cancer	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Haemoglobin—Fluorouracil—skin cancer	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Leukopenia—Bleomycin—skin cancer	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Rhinitis—Fluorouracil—skin cancer	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Haemorrhage—Fluorouracil—skin cancer	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Dizziness—Vemurafenib—skin cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Cough—Bleomycin—skin cancer	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Chills—Temozolomide—skin cancer	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Dehydration—Docetaxel—skin cancer	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Dactinomycin—skin cancer	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Anaemia—Dactinomycin—skin cancer	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Vomiting—Vemurafenib—skin cancer	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Alopecia—Temozolomide—skin cancer	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Dry skin—Docetaxel—skin cancer	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Chest pain—Bleomycin—skin cancer	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Myalgia—Bleomycin—skin cancer	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Rash—Vemurafenib—skin cancer	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Dermatitis—Vemurafenib—skin cancer	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Hypersensitivity—Imiquimod—skin cancer	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Headache—Vemurafenib—skin cancer	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Discomfort—Bleomycin—skin cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Malaise—Dactinomycin—skin cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Leukopenia—Dactinomycin—skin cancer	0.00135	0.00135	CcSEcCtD
Cefpodoxime—Dysgeusia—Temozolomide—skin cancer	0.00134	0.00134	CcSEcCtD
Cefpodoxime—Asthenia—Imiquimod—skin cancer	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Confusional state—Bleomycin—skin cancer	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Bleomycin—skin cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Back pain—Temozolomide—skin cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Pruritus—Imiquimod—skin cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Nausea—Vemurafenib—skin cancer	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Bleomycin—skin cancer	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Myalgia—Dactinomycin—skin cancer	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Tremor—Temozolomide—skin cancer	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Alopecia—Fluorouracil—skin cancer	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Diarrhoea—Imiquimod—skin cancer	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Discomfort—Dactinomycin—skin cancer	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Temozolomide—skin cancer	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Anaemia—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Anorexia—Bleomycin—skin cancer	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Agitation—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Pancytopenia—Docetaxel—skin cancer	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Hypotension—Bleomycin—skin cancer	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Malaise—Temozolomide—skin cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Dizziness—Imiquimod—skin cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Vertigo—Temozolomide—skin cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Leukopenia—Temozolomide—skin cancer	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Neutropenia—Docetaxel—skin cancer	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Palpitations—Temozolomide—skin cancer	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Dactinomycin—skin cancer	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Bleomycin—skin cancer	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Cough—Temozolomide—skin cancer	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Paraesthesia—Bleomycin—skin cancer	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Weight increased—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Convulsion—Temozolomide—skin cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Vomiting—Imiquimod—skin cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Hypertension—Temozolomide—skin cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Dyspnoea—Bleomycin—skin cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Anorexia—Dactinomycin—skin cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Rash—Imiquimod—skin cancer	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Dermatitis—Imiquimod—skin cancer	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Pneumonia—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Headache—Imiquimod—skin cancer	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Anaemia—Fluorouracil—skin cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Myalgia—Temozolomide—skin cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Anxiety—Temozolomide—skin cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Discomfort—Temozolomide—skin cancer	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Decreased appetite—Bleomycin—skin cancer	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Renal failure—Docetaxel—skin cancer	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Dry mouth—Temozolomide—skin cancer	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Stomatitis—Docetaxel—skin cancer	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Pain—Bleomycin—skin cancer	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Leukopenia—Fluorouracil—skin cancer	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Confusional state—Temozolomide—skin cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Temozolomide—skin cancer	0.00111	0.00111	CcSEcCtD
Cefpodoxime—Nausea—Imiquimod—skin cancer	0.00111	0.00111	CcSEcCtD
Cefpodoxime—Epistaxis—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Temozolomide—skin cancer	0.00109	0.00109	CcSEcCtD
Cefpodoxime—Convulsion—Fluorouracil—skin cancer	0.00109	0.00109	CcSEcCtD
Cefpodoxime—Feeling abnormal—Bleomycin—skin cancer	0.00109	0.00109	CcSEcCtD
Cefpodoxime—Agranulocytosis—Docetaxel—skin cancer	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Temozolomide—skin cancer	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Chest pain—Fluorouracil—skin cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Myalgia—Fluorouracil—skin cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Decreased appetite—Dactinomycin—skin cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Fatigue—Dactinomycin—skin cancer	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Anorexia—Temozolomide—skin cancer	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Discomfort—Fluorouracil—skin cancer	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Pain—Dactinomycin—skin cancer	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Urticaria—Bleomycin—skin cancer	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Haemoglobin—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Rhinitis—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Body temperature increased—Bleomycin—skin cancer	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Haemorrhage—Docetaxel—skin cancer	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Confusional state—Fluorouracil—skin cancer	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Oedema peripheral—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Fluorouracil—skin cancer	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Feeling abnormal—Dactinomycin—skin cancer	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Insomnia—Temozolomide—skin cancer	0.00101	0.00101	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Dactinomycin—skin cancer	0.00101	0.00101	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Fluorouracil—skin cancer	0.00101	0.00101	CcSEcCtD
Cefpodoxime—Paraesthesia—Temozolomide—skin cancer	0.001	0.001	CcSEcCtD
Cefpodoxime—Dyspnoea—Temozolomide—skin cancer	0.000994	0.000994	CcSEcCtD
Cefpodoxime—Somnolence—Temozolomide—skin cancer	0.000991	0.000991	CcSEcCtD
Cefpodoxime—Erythema multiforme—Docetaxel—skin cancer	0.000987	0.000987	CcSEcCtD
Cefpodoxime—Dyspepsia—Temozolomide—skin cancer	0.000981	0.000981	CcSEcCtD
Cefpodoxime—Anorexia—Fluorouracil—skin cancer	0.000979	0.000979	CcSEcCtD
Cefpodoxime—Abdominal pain—Dactinomycin—skin cancer	0.000975	0.000975	CcSEcCtD
Cefpodoxime—Body temperature increased—Dactinomycin—skin cancer	0.000975	0.000975	CcSEcCtD
Cefpodoxime—Hypersensitivity—Bleomycin—skin cancer	0.000974	0.000974	CcSEcCtD
Cefpodoxime—Decreased appetite—Temozolomide—skin cancer	0.000969	0.000969	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Temozolomide—skin cancer	0.000963	0.000963	CcSEcCtD
Cefpodoxime—Fatigue—Temozolomide—skin cancer	0.000961	0.000961	CcSEcCtD
Cefpodoxime—Hypotension—Fluorouracil—skin cancer	0.00096	0.00096	CcSEcCtD
Cefpodoxime—Constipation—Temozolomide—skin cancer	0.000953	0.000953	CcSEcCtD
Cefpodoxime—Pain—Temozolomide—skin cancer	0.000953	0.000953	CcSEcCtD
Cefpodoxime—Asthenia—Bleomycin—skin cancer	0.000948	0.000948	CcSEcCtD
Cefpodoxime—Chills—Docetaxel—skin cancer	0.000936	0.000936	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000936	0.000936	CcSEcCtD
Cefpodoxime—Pruritus—Bleomycin—skin cancer	0.000935	0.000935	CcSEcCtD
Cefpodoxime—Insomnia—Fluorouracil—skin cancer	0.000929	0.000929	CcSEcCtD
Cefpodoxime—Paraesthesia—Fluorouracil—skin cancer	0.000922	0.000922	CcSEcCtD
Cefpodoxime—Alopecia—Docetaxel—skin cancer	0.000922	0.000922	CcSEcCtD
Cefpodoxime—Feeling abnormal—Temozolomide—skin cancer	0.000919	0.000919	CcSEcCtD
Cefpodoxime—Dyspnoea—Fluorouracil—skin cancer	0.000916	0.000916	CcSEcCtD
Cefpodoxime—Somnolence—Fluorouracil—skin cancer	0.000913	0.000913	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Temozolomide—skin cancer	0.000912	0.000912	CcSEcCtD
Cefpodoxime—Hypersensitivity—Dactinomycin—skin cancer	0.000908	0.000908	CcSEcCtD
Cefpodoxime—Dyspepsia—Fluorouracil—skin cancer	0.000904	0.000904	CcSEcCtD
Cefpodoxime—Decreased appetite—Fluorouracil—skin cancer	0.000893	0.000893	CcSEcCtD
Cefpodoxime—Dysgeusia—Docetaxel—skin cancer	0.00089	0.00089	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000887	0.000887	CcSEcCtD
Cefpodoxime—Urticaria—Temozolomide—skin cancer	0.000886	0.000886	CcSEcCtD
Cefpodoxime—Asthenia—Dactinomycin—skin cancer	0.000884	0.000884	CcSEcCtD
Cefpodoxime—Abdominal pain—Temozolomide—skin cancer	0.000881	0.000881	CcSEcCtD
Cefpodoxime—Body temperature increased—Temozolomide—skin cancer	0.000881	0.000881	CcSEcCtD
Cefpodoxime—Back pain—Docetaxel—skin cancer	0.000879	0.000879	CcSEcCtD
Cefpodoxime—Pain—Fluorouracil—skin cancer	0.000879	0.000879	CcSEcCtD
Cefpodoxime—Feeling abnormal—Fluorouracil—skin cancer	0.000847	0.000847	CcSEcCtD
Cefpodoxime—Diarrhoea—Dactinomycin—skin cancer	0.000843	0.000843	CcSEcCtD
Cefpodoxime—Vomiting—Bleomycin—skin cancer	0.00084	0.00084	CcSEcCtD
Cefpodoxime—Anaemia—Docetaxel—skin cancer	0.00084	0.00084	CcSEcCtD
Cefpodoxime—Rash—Bleomycin—skin cancer	0.000833	0.000833	CcSEcCtD
Cefpodoxime—Dermatitis—Bleomycin—skin cancer	0.000833	0.000833	CcSEcCtD
Cefpodoxime—Hypersensitivity—Temozolomide—skin cancer	0.000821	0.000821	CcSEcCtD
Cefpodoxime—Urticaria—Fluorouracil—skin cancer	0.000816	0.000816	CcSEcCtD
Cefpodoxime—Syncope—Docetaxel—skin cancer	0.000815	0.000815	CcSEcCtD
Cefpodoxime—Leukopenia—Docetaxel—skin cancer	0.000813	0.000813	CcSEcCtD
Cefpodoxime—Body temperature increased—Fluorouracil—skin cancer	0.000812	0.000812	CcSEcCtD
Cefpodoxime—Palpitations—Docetaxel—skin cancer	0.000803	0.000803	CcSEcCtD
Cefpodoxime—Asthenia—Temozolomide—skin cancer	0.0008	0.0008	CcSEcCtD
Cefpodoxime—Loss of consciousness—Docetaxel—skin cancer	0.000799	0.000799	CcSEcCtD
Cefpodoxime—Cough—Docetaxel—skin cancer	0.000793	0.000793	CcSEcCtD
Cefpodoxime—Pruritus—Temozolomide—skin cancer	0.000789	0.000789	CcSEcCtD
Cefpodoxime—Convulsion—Docetaxel—skin cancer	0.000787	0.000787	CcSEcCtD
Cefpodoxime—Nausea—Bleomycin—skin cancer	0.000785	0.000785	CcSEcCtD
Cefpodoxime—Hypertension—Docetaxel—skin cancer	0.000784	0.000784	CcSEcCtD
Cefpodoxime—Vomiting—Dactinomycin—skin cancer	0.000784	0.000784	CcSEcCtD
Cefpodoxime—Rash—Dactinomycin—skin cancer	0.000777	0.000777	CcSEcCtD
Cefpodoxime—Myalgia—Docetaxel—skin cancer	0.000773	0.000773	CcSEcCtD
Cefpodoxime—Chest pain—Docetaxel—skin cancer	0.000773	0.000773	CcSEcCtD
Cefpodoxime—Diarrhoea—Temozolomide—skin cancer	0.000763	0.000763	CcSEcCtD
Cefpodoxime—Hypersensitivity—Fluorouracil—skin cancer	0.000757	0.000757	CcSEcCtD
Cefpodoxime—Dry mouth—Docetaxel—skin cancer	0.000756	0.000756	CcSEcCtD
Cefpodoxime—Confusional state—Docetaxel—skin cancer	0.000748	0.000748	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Docetaxel—skin cancer	0.000741	0.000741	CcSEcCtD
Cefpodoxime—Dizziness—Temozolomide—skin cancer	0.000737	0.000737	CcSEcCtD
Cefpodoxime—Nausea—Dactinomycin—skin cancer	0.000732	0.000732	CcSEcCtD
Cefpodoxime—Shock—Docetaxel—skin cancer	0.00073	0.00073	CcSEcCtD
Cefpodoxime—Pruritus—Fluorouracil—skin cancer	0.000727	0.000727	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Docetaxel—skin cancer	0.000726	0.000726	CcSEcCtD
Cefpodoxime—Vomiting—Temozolomide—skin cancer	0.000709	0.000709	CcSEcCtD
Cefpodoxime—Anorexia—Docetaxel—skin cancer	0.000707	0.000707	CcSEcCtD
Cefpodoxime—Rash—Temozolomide—skin cancer	0.000703	0.000703	CcSEcCtD
Cefpodoxime—Diarrhoea—Fluorouracil—skin cancer	0.000703	0.000703	CcSEcCtD
Cefpodoxime—Dermatitis—Temozolomide—skin cancer	0.000702	0.000702	CcSEcCtD
Cefpodoxime—Headache—Temozolomide—skin cancer	0.000699	0.000699	CcSEcCtD
Cefpodoxime—Hypotension—Docetaxel—skin cancer	0.000693	0.000693	CcSEcCtD
Cefpodoxime—Dizziness—Fluorouracil—skin cancer	0.000679	0.000679	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000676	0.000676	CcSEcCtD
Cefpodoxime—Insomnia—Docetaxel—skin cancer	0.000671	0.000671	CcSEcCtD
Cefpodoxime—Paraesthesia—Docetaxel—skin cancer	0.000666	0.000666	CcSEcCtD
Cefpodoxime—Nausea—Temozolomide—skin cancer	0.000662	0.000662	CcSEcCtD
Cefpodoxime—Dyspnoea—Docetaxel—skin cancer	0.000661	0.000661	CcSEcCtD
Cefpodoxime—Somnolence—Docetaxel—skin cancer	0.000659	0.000659	CcSEcCtD
Cefpodoxime—Vomiting—Fluorouracil—skin cancer	0.000653	0.000653	CcSEcCtD
Cefpodoxime—Dyspepsia—Docetaxel—skin cancer	0.000653	0.000653	CcSEcCtD
Cefpodoxime—Rash—Fluorouracil—skin cancer	0.000648	0.000648	CcSEcCtD
Cefpodoxime—Dermatitis—Fluorouracil—skin cancer	0.000647	0.000647	CcSEcCtD
Cefpodoxime—Decreased appetite—Docetaxel—skin cancer	0.000645	0.000645	CcSEcCtD
Cefpodoxime—Headache—Fluorouracil—skin cancer	0.000644	0.000644	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Docetaxel—skin cancer	0.00064	0.00064	CcSEcCtD
Cefpodoxime—Fatigue—Docetaxel—skin cancer	0.000639	0.000639	CcSEcCtD
Cefpodoxime—Pain—Docetaxel—skin cancer	0.000634	0.000634	CcSEcCtD
Cefpodoxime—Constipation—Docetaxel—skin cancer	0.000634	0.000634	CcSEcCtD
Cefpodoxime—Feeling abnormal—Docetaxel—skin cancer	0.000611	0.000611	CcSEcCtD
Cefpodoxime—Nausea—Fluorouracil—skin cancer	0.00061	0.00061	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Docetaxel—skin cancer	0.000606	0.000606	CcSEcCtD
Cefpodoxime—Abdominal pain—Docetaxel—skin cancer	0.000586	0.000586	CcSEcCtD
Cefpodoxime—Body temperature increased—Docetaxel—skin cancer	0.000586	0.000586	CcSEcCtD
Cefpodoxime—Hypersensitivity—Docetaxel—skin cancer	0.000546	0.000546	CcSEcCtD
Cefpodoxime—Asthenia—Docetaxel—skin cancer	0.000532	0.000532	CcSEcCtD
Cefpodoxime—Pruritus—Docetaxel—skin cancer	0.000525	0.000525	CcSEcCtD
Cefpodoxime—Diarrhoea—Docetaxel—skin cancer	0.000507	0.000507	CcSEcCtD
Cefpodoxime—Dizziness—Docetaxel—skin cancer	0.00049	0.00049	CcSEcCtD
Cefpodoxime—Vomiting—Docetaxel—skin cancer	0.000471	0.000471	CcSEcCtD
Cefpodoxime—Rash—Docetaxel—skin cancer	0.000468	0.000468	CcSEcCtD
Cefpodoxime—Dermatitis—Docetaxel—skin cancer	0.000467	0.000467	CcSEcCtD
Cefpodoxime—Headache—Docetaxel—skin cancer	0.000465	0.000465	CcSEcCtD
Cefpodoxime—Nausea—Docetaxel—skin cancer	0.00044	0.00044	CcSEcCtD
